<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="36763">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01822821</url>
  </required_header>
  <id_info>
    <org_study_id>13-269</org_study_id>
    <nct_id>NCT01822821</nct_id>
  </id_info>
  <brief_title>Pain Control After Cardiac Surgery Using Intravenous Acetaminophen</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the efficacy of IV acetaminophen; compared to a placebo, in reducing opioid
      consumption and/or pain intensity scores after cardiac surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>reduction in opioid consumption</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluate the efficacy of IV acetaminophen; compared to a placebo, in reducing opioid consumption and/or pain intensity scores after cardiac surgery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pain intensity</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluate the efficacy of IV acetaminophen; compared to a placebo, in reducing opioid consumption and/or pain intensity scores after cardiac surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>adverse events</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluate whether IV acetaminophen reduced opioid related adverse events, duration of MV (Mechanical Ventilation), and ICU (Intensive Care Unit)and hospital LOS (Length of Stay).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of MV (Mechanical Ventilation)</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluate whether IV acetaminophen reduced opioid related adverse events, duration of MV (Mechanical Ventilation), and ICU (Intensive Care Unit)and hospital LOS (Length of Stay).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU (Intensive Care Unit)length of stay</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluate whether IV acetaminophen reduced opioid related adverse events, duration of MV (Mechanical Ventilation), and ICU (Intensive Care Unit)and hospital LOS (Length of Stay).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital length of stay</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluate whether IV acetaminophen reduced opioid related adverse events, duration of MV (Mechanical Ventilation), and ICU (Intensive Care Unit)and hospital LOS (Length of Stay).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>persistent incisional pain</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluate whether IV acetaminophen decreases incidence of persistent incisional pain.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>IV Acetaminophen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive up to four doses of IV Acetaminophen (1000mg)every six hours after surgery along with standard PCA (patient controlled) opioids.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive up to four doses of IV placebo every six hours after surgery along with standard PCA (patient controlled) opioids.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV Acetaminophen</intervention_name>
    <description>Patients will receive up to four doses of IV Acetaminophen (1000mg)every six hours after surgery along with standard PCA (patient controlled) opioids.</description>
    <arm_group_label>IV Acetaminophen</arm_group_label>
    <other_name>1000mg IV Acetaminophen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Patients will receive up to four doses placebo every six hours after surgery along with standard PCA (patient controlled) opioids.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>inactive substance</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  - Males or females 18 years of age or older.

          -  Non-emergency cardiac surgery via a midline sternotomy.

        Exclusion Criteria:

          1. Redo cardiac surgery.

          2. Combined CABG (Coronary Artery Bypass Graft)&amp; valve replacement, multiple valve
             replacements, Ascending aortic or aortic arch surgery.

          3. Weight &lt; 50 Kg or Body mass index &gt; 38 kg/m2.

          4. Left ventricle EF ยกร 35% ,Right ventricular moderate or severe dysfunction.

          5. Severe (3-4 +) Tricuspid Regurgitation.

          6. Recent stroke (within 6 months).

          7. Severe lung disease requiring home O2 therapy.

          8. Preoperative renal insufficiency (Creatinine &gt; 2.0) or on dialysis.

          9. History of liver cirrhosis or active liver disease.

         10. Chronic pain conditions controlled by preoperative opioid administration.

         11. Known allergy to acetaminophen or fentanyl.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Negmeldeen Mamoun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Negmeldeen Mamoun, MD</last_name>
    <phone>216/444-7783</phone>
    <email>mamounn@ccf.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Roberta Johnson</last_name>
    <phone>216-444-9950</phone>
    <email>johnsor13@ccf.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Negmeldeen Mamoun, MD</last_name>
      <phone>216-444-7783</phone>
      <email>mamounn@ccf.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 6, 2014</lastchanged_date>
  <firstreceived_date>March 28, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Males or females</keyword>
  <keyword>18 years of age or older.</keyword>
  <keyword>Non-emergency</keyword>
  <keyword>cardiac surgery</keyword>
  <keyword>midline sternotomy.</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
